Navigation Links
Hospira Reports Third-Quarter 2011 Results
Date:10/26/2011

$1.5 million reported in Research and development and $3.8 million reported in Selling, general and administrative. These charges include acquisition and integration costs resulting from acquisitions including Javelin Pharma and a generic injectable business by Hospira India.(F)

Loss on early debt extinguishment of $36.8 million pre-tax reported in Other (income) expenses, net relates to a provision for the early extinguishment of 5.55% notes originally due March 2012, which was paid in October 2010.(1)

Gross profit is defined as Net sales less Cost of products sold.(2)

Adjusted Net Income is shown net of tax of $29.0 million and $29.9 million for the three months ended September 30, 2011 and 2010, respectively, based on the statutory tax rate in the various tax jurisdictions in which the adjustments occurred.(3)

The Non-GAAP financial measures contained in this press release (including adjusted gross profit, adjusted income from operations, adjusted net income and adjusted diluted Earnings Per Share) adjust for certain specified items. All Non-GAAP financial measures are intended to supplement the applicable GAAP measures and should not be considered in isolation from, or a replacement for, financial measures prepared in accordance with GAAP. Refer to Hospira’s filing on Form 8-K filed on October 26, 2011 for additional information.Hospira, Inc.Reconciliation of GAAP to Non-GAAP Financial Measures(Unaudited)(dollars in millions, except for per share amounts)Nine months ended September 30, 2011 Reconciliation of GAAP to Non-GAAP Financial Measures:Gross Profit (1)Income From

OperationsNet Income (2)Diluted EPSGAAP financial measures$
,116.4$
269.1$
204.6$
.21Specified items:   Project Fuel and related charges (A)

5.09.66.30.04   Facilities Optimization charges (B)

0.81.10.70.01   Amortization and impairment of certain intangible assets (C)'/>"/>

SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Hospira Announces Certain Preliminary Third-Quarter 2011 Results
2. Hospira to Host Conference Call for Third-Quarter 2011 Results
3. Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
4. Hospira to Host 2011 Investor Day
5. Hospira to Present at the Morgan Stanley Global Healthcare Conference
6. Hospira Expands Board of Directors
7. Hospira Announces U.S. Approval of Solution Version of Gemcitabine Injection
8. Hospira Reports Second-Quarter 2011 Results
9. Hospira to Host Conference Call for Second-Quarter 2011 Results
10. Hospira Receives Health Canada Regulatory Approval for Symbiqâ„¢ Infusion System Software Upgrade
11. Hospira to Present at the Sanford C. Bernstein Twenty-Seventh Annual Strategic Decisions Conference 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 As health officials across the Midwest warn against ... in Michigan will offer free diagnostic ... Meijer pharmacists to administer tests and, in some cases, fill ... participating in the study. The Grand ...
(Date:1/15/2014)... the leading health care supply chain expertise, analytics and ... national contracts that expand its portfolio to provide hospital ... These include manufacturer product and service agreements, as well ... IT consulting support. New Novation agreements ...
(Date:1/15/2014)... , Jan. 15, 2014 Massachusetts General ... AMGN ) announced today that they ... and validate new therapeutic targets and develop novel ... disorder that affects millions worldwide. The MGH-Broad-Amgen collaboration ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4
... ATLANTA, Dec. 12, 2011 Digital Assent, provider of ... and patient education solution , today announced it has ... at the 2011 Spirit of Endeavor Awards presented by ... Digital Assent was honored with this prestigious ...
... Center has joined managed technology cooperative Hosted Technology Exchange ... paired with major cost savings. Membership in ... in short and long-term operating and capital expenses and ... the coming years. "We have joined ...
Cached Medicine Technology:Digital Assent Wins Back-to-Back Spirit of Endeavor Awards, This Year for Top "Emerging Technology Company" 2Digital Assent Wins Back-to-Back Spirit of Endeavor Awards, This Year for Top "Emerging Technology Company" 3Hosted Technology Exchange Welcomes Akron General 2
(Date:4/20/2014)... type of cell in the lining of the bladder ... according to researchers at the Stanford University School of ... first to pinpoint the normal cell type that can ... first to show that most bladder cancers and their ... explains why many human bladder cancers recur after therapy. ...
(Date:4/18/2014)... School of Medicine researchers have been awarded two-year grants ... Nordisk announced this month. Of the 110 initial submissions ... Science Forum Program, only four projects were funded, three ... are Jonathan Powell, M.D., Ph.D.; G. William Wong, Ph.D.; ... a professor of oncology, will use his $500,000 proof ...
(Date:4/18/2014)... French . ... medicine. A team led by Ludwik Leibler from the ... Didier Letourneur from the Laboratoire Recherche Vasculaire Translationnelle (INSERM/Universits ... the principle of adhesion by aqueous solutions of nanoparticles ... and tissues. This easy-to-use gluing method has been tested ...
(Date:4/17/2014)... relief targets that could be used to provide ... College London made the discovery when researching how ... the body. , Dr Marzia Malcangio said: "We ... generation and our findings could help chemotherapy patients ... potential side effect of some chemotherapy drugs (such ...
(Date:4/17/2014)... 17, 2014) Two recent papers by a ... colleagues may help scientists develop treatments or vaccines ... Japanese encephalitis and other disease-causing flaviviruses. , Jeffrey ... molecular genetics at the School of Medicine and ... Medical Institute, and colleagues recently published articles in ...
Breaking Medicine News(10 mins):Health News:Stanford scientists identify source of most cases of invasive bladder cancer 2Health News:Stanford scientists identify source of most cases of invasive bladder cancer 3Health News:Stanford scientists identify source of most cases of invasive bladder cancer 4Health News:Stanford scientists identify source of most cases of invasive bladder cancer 5Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3Health News:New pain relief targets discovered 2Health News:CU researchers discover target for treating dengue fever 2
... disorder caused by abnormal surges in the electrical circuits of ... affect more than 2 million people worldwide. More than half ... medications. // ,Researchers now say that a new study ... compared to drug therapy when treating those with temporal lobe ...
... After analyzing nearly 30 years worth of data on breast ... more advanced stages of disease at diagnosis and those who ... stages, are the most likely to die from the disease. ... cancer than white women, as are those whose tumors are ...
... Breast cancer may be detected earlier using a computer-assisted ... study. CAD is a computer-based analysis designed to find ... that appear only as tiny white specks on mammography ... ,Researchers reviewed the cases of 519 patients ...
... the fluid that flows in and out of the eye ... new study shows pressure-lowering eye drops may delay or ... 50 percent of blacks, who are at higher risk for ... leading cause of blindness in the black community, and as ...
... to erase the signs of aging. However at present researchers ... used to treat a chronic condition known as gastroparesis. ... after a meal. It may be for solid food or ... condition causes a person to feel full after just a ...
... found that people who get lots of vitamin E ... cancer as those who take in relatively little. Researchers once ... // an important safeguard against heart attacks. But that idea ... effect .Now, some think the vitamin may protect against cancer ...
Cached Medicine News:Health News:Vitamin E Found To reduce bladder cancer risk 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: